{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:16:11Z","timestamp":1792404971729,"version":"4.4.0"},"reference-count":55,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lymphoma in pregnancy is an uncommon occurrence. This diagnosis is challenging, and a multidisciplinary team of specialists in obstetrics, anesthesiology, neonatology, hematology psychology should participate in the management of this condition. The choice of treatment regimen depends on the histotype and the gestational age. In Hodgkin lymphoma, ABVD is safe if administered after the thirteenth week of pregnancy. In indolent non\u2010Hodgkin Lymphomas (NHL) a watchful waiting approach is reasonable; in case of aggressive NHLs, if the diagnosis occurs in the first gestational weeks, a termination of the pregnancy might be considered or if it occurs after the thirteenth week of pregnancy, a standard R\u2010CHOP regimen is safe. Regarding new anti\u2010lymphoma drugs, available data on the potential fetotoxicity of these agents are limited. Data collection regarding the use of new drugs in pregnant patients is mandatory in order to learn more about their safety and facilitating clinical decision making in this setting of patients.<\/jats:p>","DOI":"10.1002\/hon.3150","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T21:16:00Z","timestamp":1686345360000},"page":"70-74","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lymphomas in pregnancy"],"prefix":"10.1002","volume":"41","author":[{"given":"Maria Cristina","family":"Pirosa","sequence":"first","affiliation":[{"name":"Clinic of Medical Oncology Oncology Institute of Southern Switzerland Ente Ospedaliero Cantonale  Bellinzona Switzerland"},{"name":"Faculty of Biomedical Science Universit\u00e0 della Svizzera italiana  Lugano Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedro Alessandro","family":"Peccatori","sequence":"additional","affiliation":[{"name":"Gynecologic Oncology Department European Institute of Oncology IRCCS  Milano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-71274-9_11"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000961"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt199"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.10.014"},{"key":"e_1_2_4_6_1","first-page":"1813","article-title":"Safety of radiographic imaging during pregnancy","volume":"59","author":"Toppenberg KS","year":"1999","journal-title":"Am Fam Physician"},{"key":"e_1_2_4_7_1","first-page":"623","article-title":"Imaging strategies in the pregnant cancer patient","volume":"27","author":"Nicklas AH","year":"2000","journal-title":"Semin Oncol"},{"key":"e_1_2_4_8_1","first-page":"559","article-title":"Low levels of X\u2010irradiation and the early mammalian embryo","volume":"87","author":"Rugh R","year":"1962","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.263959"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.17.4110"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1992.21"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(16)35688-5"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198604000-00009"},{"key":"e_1_2_4_14_1","first-page":"133","article-title":"Hodgkin's disease complicating pregnancy","volume":"36","author":"Tawil E","year":"1985","journal-title":"J Can Assoc Radiol"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-95-6-669"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7020.1607"},{"key":"e_1_2_4_17_1","first-page":"423","article-title":"Influence of pregnancy on the development of Hodgkin's disease","volume":"17","author":"Jouet JP","year":"1988","journal-title":"Presse Med"},{"key":"e_1_2_4_18_1","first-page":"336","article-title":"Hodgkin's disease and pregnancy","volume":"69","author":"Gobbi PG","year":"1984","journal-title":"Haematologica"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(04)01466-4"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.7-6-573"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)32984-2"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-613570"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1805104"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000324"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015789"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(17)30696-4"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-295444"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew493"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000453"},{"key":"e_1_2_4_30_1","first-page":"276","article-title":"High expression of the CD30 molecule in human decidual cells","volume":"145","author":"Ito K","year":"1994","journal-title":"Am J Pathol"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12956"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100831"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.21176"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/jgo.17.00019"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.09.008"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/cmr.0000000000000657"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2018.03.003"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/cmr.0000000000000586"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2018.03.005"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/qco.0000000000000372"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1407222"},{"key":"e_1_2_4_42_1","first-page":"483","article-title":"Ibrutinib (imbruvica): a novel targeted therapy for chronic lymphocytic leukemia","volume":"39","author":"Parmar S","year":"2014","journal-title":"P T"},{"key":"e_1_2_4_43_1","first-page":"476","article-title":"Pharmaceutical approval update","volume":"41","author":"Kaufman MB","year":"2016","journal-title":"P T"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016349.2010.512070"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11097"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(80)90085-6"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.62.4445"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-013-0163-4"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1159\/000473880"},{"key":"e_1_2_4_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj053"},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2019.1615878"},{"key":"e_1_2_4_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.49.8220"},{"key":"e_1_2_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2017.05.008"},{"key":"e_1_2_4_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg745"},{"key":"e_1_2_4_55_1","doi-asserted-by":"publisher","DOI":"10.3816\/clm.2001.n.023"},{"key":"e_1_2_4_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-2368-y"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.3150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T06:32:40Z","timestamp":1692426760000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.3150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":55,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1002\/hon.3150"],"URL":"https:\/\/doi.org\/10.1002\/hon.3150","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"2023-03-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}